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Abstract
Hematogenous dissemination is important for infection by many bacterial pathogens, but is poorly understood because of
the inability to directly observe this process in living hosts at the single cell level. All disseminating pathogens must tether
to the host endothelium despite significant shear forces caused by blood flow. However, the molecules that mediate
tethering interactions have not been identified for any bacterial pathogen except E. coli, which tethers to host cells via a
specialized pillus structure that is not found in many pathogens. Furthermore, the mechanisms underlying tethering have
never been examined in living hosts. We recently engineered a fluorescent strain of Borrelia burgdorferi, the Lyme disease
pathogen, and visualized its dissemination from the microvasculature of living mice using intravital microscopy. We found
that dissemination was a multistage process that included tethering, dragging, stationary adhesion and extravasation. In the
study described here, we used quantitative real-time intravital microscopy to investigate the mechanistic features of the
vascular interaction stage of B. burgdorferi dissemination. We found that tethering and dragging interactions were
mechanistically distinct from stationary adhesion, and constituted the rate-limiting initiation step of microvascular
interactions. Surprisingly, initiation was mediated by host Fn and GAGs, and the Fn- and GAG-interacting B. burgdorferi
protein BBK32. Initiation was also strongly inhibited by the low molecular weight clinical heparin dalteparin. These findings
indicate that the initiation of spirochete microvascular interactions is dependent on host ligands known to interact in vitro
with numerous other bacterial pathogens. This conclusion raises the intriguing possibility that fibronectin and GAG
interactions might be a general feature of hematogenous dissemination by other pathogens.
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Introduction
Hematogenous dissemination of pathogenic organisms is an
important feature of disease progression. However, dissemination
is poorly understood, in large part because of the difficulty in
studying this process directly in living organisms under the shear
stress conditions that characterize the host vasculature. One such
disseminating pathogen is the spirochete Borrelia burgdorferi,a
primarily extracellular bacterium causing Lyme disease, also
referred to as Lyme borreliosis [1].
Pathogenic spirochetes cause a number of emerging and re-
emerging diseases, including syphilis, leptospirosis, relapsing fever
and Lyme disease [2–5]. B. burgdorferi is transmitted to the dermis
of vertebrate hosts during the blood meal of Ixodes ticks, and
subsequently disseminates to other tissues and organs during the
hematogenous phase of infection [1]. B. burgdorferi and other
spirochetes interact with endothelial cells under static conditions in
vitro [6–8]. However, until recently, spirochete-vascular interac-
tions have never been directly examined in the host itself, or under
the fluid shear forces that are present at dissemination sites [9].
To facilitate direct study of hematogenous dissemination we
recently generated a fluorescent infectious strain of B. burgdorferi,
and used intravital microscopy (IVM) to directly visualize its
interaction with and extravasation from the microvasculature of
living murine hosts (as summarized in Fig. 1A–C) [9]. IVM is a
powerful tool for studying the dissemination and transmigration of
tumor and immune cells in living hosts, but it is only recently that
this technique has begun to be applied to the study of host-
pathogen interactions [10,11].
The results of our recent study indicated that B. burgdorferi
dissemination from the host microvasculature in vivo is a
progressive, multi-stage process consisting of several successive
steps: transient and dragging interactions (collectively referred to
as short-term interactions), followed by stationary adhesion and
extravasation. Short-term interactions constitute the majority of
spirochete-endothelial associations (89% and 10% for transient
PLoS Pathogens | www.plospathogens.org 1 October 2008 | Volume 4 | Issue 10 | e1000169and dragging interactions, respectively), take less than one second
(transient interactions) or 3–20s (dragging interactions) to travel
100 mm along the vessel wall, and occur primarily on the surface
of endothelial cells and not at endothelial junctions [9]. Transient
interactions are characterized by a tethering-type attachment-
detachment cycle of association in which part of the spirochete
adheres briefly to the endothelium before being displaced by blood
flow, whereas dragging spirochetes adhere along much of the
length of the bacterium, and creep more slowly along the vessel
wall [9]. In contrast, stationary adhesions (1% of interactions) do
not move along the vessel wall, occur chiefly, but not exclusively,
at endothelial junctions, and entail a more intimate association
with the endothelium than short-term interactions [9]. Finally,
spirochete extravasation (,0.12% of interactions) also occurs
primarily, but not exclusively, at endothelial junctions, and is a
triphasic process consisting of a rapid, end-first initial penetration
of the endothelium, followed by a prolonged period of recipro-
cating movement, and ending with a rapid exit phase in which the
bacterium bursts out of the vessel and migrates rapidly into the
surrounding tissue [9].
In vitro studies have shown that B. burgdorferi binds several host
molecules that might mediate endothelial interactions in vivo,
including fibronectin (Fn), integrins, heparan sulfate-type glycos-
aminoglycans (GAGs) and regulators of the complement cascade
[12-20]. A broad array of pathogens have been shown to interact
with these ubiquitous host molecules in direct binding assays and
tissue culture models in vitro; most of these studies have been
performed in the absence of shear forces, microvascular
endothelium or a functioning immune system, and so the potential
contribution of such interactions to hematogenous dissemination
in the living host is unknown. To date, 19 candidate adhesin genes
have been identified in B. burgdorferi, two of which are known to
interact with integrins (P66 and BBB07), and two of which can
associate with heparan sulfate GAGs (BBK32 and Bgp)
[16,17,19,21–25]. B. burgdorferi encodes one characterized Fn
binding protein, BBK32, and appears to express a number of
others [12,16,24]. Five B. burgdorferi CRASP proteins that interact
with complement cascade regulating proteins factor H, FHL-1 and
FHR-1 have also been identified [20,26,27], but their potential
contributions to endothelial cell adhesion are unknown.
In the work described here we used IVM to explore the
mechanistic basis for B. burgdorferi interactions with the microvas-
culature of living mice. We found that the initiating and stationary
adhesion stages of microvascular interactions were mechanistically
distinct but inter-dependent events, and that BBK32, Fn and
GAGs played a substantial role in initiation events. These findings
and the methodology described here provide a framework for
investigating the role of Fn and GAGs in vascular interactions
during hematogenous dissemination by B. burgdorferi and possibly
other pathogens.
Results
Host GAGs promote B. burgdorferi interactions with the
microvasculature in vivo
To quantitatively analyze B. burgdorferi interactions with the
microvascular endothelium in vivo we employed conventional
epifluorescence IVM to examine interactions in the flank skin of
mice after intravenous inoculation with 4610
8 spirochetes (Fig. 1
and Videos S1 and S2). Conventional epifluorescence IVM was
used instead of spinning disk confocal IVM because it is more
effective for imaging the rapid associations that constitute the bulk
of B. burgdorferi microvascular interactions (Fig. 1). Analysis was
performed in post-capillary venules, where interactions could be
most accurately quantified. For all experiments reported in this
manuscript, data describing the numbers of recorded vessels and
mice for each experimental condition, as well as the average time
after spirochete injection at which recordings were made are
provided in the Figure Legends. As we have recently reported,
during the experimental observation period no signs of endothelial
Figure 1. Intravital microscopy to study B. burgdorferi microvascular interactions in vivo. A) Table summarizing the properties of spinning
disk confocal and conventional epifluorescence intravital microscopy (IVM) with respect to visualization of B. burgdorferi vascular interactions in situ.
B) Spinning disk confocal and C) conventional epifluorescence micrographs of fluorescent infectious B. burgdorferi in the skin microvasculature of a
living mouse. Blood vessels in b) were visualized using AlexaFluor555-conjugated antibody to PECAM-1 (red). Spinning disk confocal and
conventional epifluorescence IVM videos from the microvasculature are presented in Videos S1 and S2, respectively.
doi:10.1371/journal.ppat.1000169.g001
Author Summary
Many bacterial pathogens can cause systemic illness by
disseminating through the blood to distant target sites.
However, hematogenous dissemination is still poorly
understood, in part because of an inability to directly
observe this process in living hosts in real time and at the
level of individual pathogens. We recently engineered a
fluorescent strain of Borrelia burgdorferi, the Lyme disease
pathogen, and visualized its dissemination from the
microvasculature of living mice using intravital microsco-
py. We found that dissemination was a multistage process
that included tethering, dragging, stationary adhesion and
extravasation. In the study described here, we used
quantitative real-time intravital microscopy to investigate
the mechanistic features of the vascular interaction stage
of B. burgdorferi dissemination in living hosts. We found
that tethering and dragging interactions (collectively
referred to as initiation interactions) were mechanistically
distinct from stationary adhesion. Initiation of microvas-
cular interactions required the B. burgdorferi protein
BBK32, and host ligands fibronectin and glycosaminogly-
cans. Initiation interactions were also strongly inhibited by
the low molecular weight clinical heparin dalteparin. Since
numerous bacterial pathogens can interact with fibronec-
tin and glycosaminoglycans in vitro, these observations
raise the intriguing possibility that fibronectin and
glycosaminoglycan recruitment might be a feature of
hematogenous dissemination by other pathogens.
Dissemination of B. burgdorferi
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adhesion in dermal postcapillary venules is an indicator of local
activation, and can be measured by using the dye rhodamine 6G
to fluorescently label all circulating leukocytes and then counting
the number of adherent leukocytes in a 100 mm length of vessel
[28]. The presence of infectious B. burgdorferi in the vasculature for
as long as 70 minutes after injection of spirochetes did not
significantly alter leukocyte adhesion from the baseline levels
observed in the absence of B. burgdorferi (1.562/+0.29 vs 1.752/
+1.15 adhered leukocytes/100 mm, respectively; P=0.797; N=50
vessels from 5 mice). The observed number of leukocyte adhesions
was normal for the dermal microvasculature of mice [28].
As shown in Fig. 2, the ability to interact with the
microvascular endothelium was specific to infectious spirochetes.
When mice were injected with non-infectious B. burgdorferi
exhibiting the same fluorescence intensity as infectious spirochetes
(Fig. 2A and B), transient interactions were reduced by 94%
(Fig. 2C). Furthermore, non-infectious B. burgdorferi did not form
many dragging interactions and no detectable stationary adhesions
(Fig. 2B and C). Non-infectious spirochetes were never observed
escaping the microvasculature. These observations indicated that
early-stage interaction events were essential for sustained associ-
ation and vascular escape. These observations also demonstrated
that microvascular interactions were dependent on B. burgdorferi
proteins expressed only in the infectious strain.
Many bacterially-encoded proteins interact with host cells via
GAGs[29],andanumberofpreviousinvitrostudies performed under
static conditions have found that B. burgdorferi can bind to GAGs and
that exogenously applied GAGs can competitively inhibit interaction
of B. burgdorferi with cell monolayers [13,15,30,31]. Therefore, we
investigated the potential role of endothelial host cell GAGs in
spirochete microvascular association in vivo. Interaction rates were
first examined in the presence and absence of a therapeutic low
molecular weight heparin compound, dalteparin (Fragmin, average
molecular weight 5 kDa). Dalteparin was used at a concentration
previously shown to block leukocyte rolling in vivo [32]. Dalteparin
(200 ml of a 25 I.U./ml solution) was injected via the femoral vein
15 minutes before intravenous inoculation with infectious spirochetes
(see Materials and Methods). As shown in Fig. 3A, dalteparin
treatment did not cause any significant change in transient
interactions between fluorescent, infectious B. burgdorferi and the
vascular endothelium. However, dragging interactions were signifi-
cantly reduced by 72% (Fig. 3B) while the number of stationary
adhesions were also reduced by dalteparin treatment to a similar
extent (Fig. 3C, 76% of controls).
Similar experiments were performed with dextran sulphate
(Fig. 3D–F), a 500 kDa high molecular weight GAG analogue,
which interacts in vitro with infectious but not non-infectious B.
burgdorferi [30]. In these experiments, dextran sulfate was incubated
with infectious B. burgdorferi for 30 minutes, followed by extensive
washing, prior to B. burgdorferi administration to the animal, as this
compound was toxic when injected directly into the mouse
bloodstream. The concentration of dextran sulfate used in
preincubations (20 mg/ml) was the dose that has been previously
shown in vitro to maximally inhibit B. burgdorferi interaction with
endothelial cells without altering spirochete morphology or
motility [30,31]. Preincubation of infectious B. burgdorferi with
dextran sulfate caused a slight (30%) reduction in the number of
transient interactions, but dragging interactions were reduced by
80% (Fig. 3D and E). A similar reduction in the number of
stationary adhesions was also observed (Fig. 3F).
The results from the dalteparin and dextran sulphate experi-
ments indicated that host GAGs play an important role in
dragging interactions between B. burgdorferi and the microvascular
endothelium in vivo, and that competition with a high molecular
weight GAG analogue (dextran sulphate) also inhibited transient
interactions. The similar levels of inhibition of dragging interac-
tions and stationary adhesions caused by treatment with GAGs
suggested that reductions in stationary adhesion were the result of
inhibition of dragging. This in turn implied that additional host
and spirochete molecules might contribute to stationary adhesion.
However, the results of these experiments alone did not rule out
the possibility that GAGs played a role in stationary adhesion.
The B. burgdorferi GAG- and Fn-binding protein BBK32 is
sufficient for transient and dragging microvascular
interactions in vivo
ManybacterialadhesinscaninteractwithGAGs,eitherdirectly,or
indirectlyviatheir association with hostmolecules such as fibronectin,
Figure 2. Interaction of infectious and non-infectious fluorescent B. burgdorferi with the microvasculature of a living murine host.
Micrographs of infectious (A) and non-infectious (B) GFP-expressing B. burgdorferi visualized on slides by epifluorescence microscopy. (C) Graphical
summary of infectious and non-infectious B. burgdorferi interactions in postcapillary venules of the skin microvasculature. The number of interactions/
minute in each interaction class was determined by measuring interactions from video footage of conventional epifluorescence IVM. The percentages
above the bars for non-infectious spirochetes indicate the non-infectious interaction rate expressed as a percentage of the interaction rate of
infectious spirochetes. Sample footage of the videos used to measure spirochete interactions is presented in Video S2. A total of 8,343 spirochete
interactions in 85 venules from 17 mice (n=8 and n=9, respectively, for experiments performed with non-infectious and infectious B. burgdorferi)
were analyzed. Standard error bars are indicated for each interaction class. P-values for this figure and all others were determined using a two-tailed
non-parametric Student’s t-test. Microvascular interactions were measured between 5 and 45 minutes after spirochete injection. The average time
after injection for all recordings made with infectious and non-infectious B. burgdorferi was 15.92/+8.1 and 14.12/+9.3 min, respectively.
doi:10.1371/journal.ppat.1000169.g002
Dissemination of B. burgdorferi
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coagulation system; furthermore, GAGs can act as bridging
molecules that facilitate interactions between pathogen adhesins
and host receptors [29]. In an effort to identify spirochete adhesins
mediating GAG-dependent microvascular interactions in vivo,w e
PCR-amplified and sequenced all candidate B. burgdorferi adhesin
genes identified to date [16,17,19,21–25], using genomic DNA
extracted from our fluorescent infectious and non-infectious strains
(Table S1). This approach indicated that the genes encoding
BBK32, VlsE, OspF, ErpL and ErpK were absent or mutated in the
non-infectious strain (Table S1). It is possible that VlsE, OspF, ErpL
and ErpK could mediate GAG-dependent host interactions directly
or through recruitment of host molecules such as complement
cascade regulators; however, interaction of these proteins with GAGs
has not been directly demonstrated. In contrast, BBK32 has recently
been shown to bind to host GAGs and to rescue the ability of non-
infectious B. burgdorferi to interact with endothelial cells in vitro [25]. It
was, therefore, of interest to investigate a possible role for BBK32 in
B. burgdorferi interactions with the microvasculature in the living
mouse. The bbk32 coding sequence, under the control of the ospC
promoter [25], was cloned into the GFP expression construct and the
resultingplasmidwasusedtotransformtheparentalnon-infectiousB.
burgdorferi strain. Both parental and complemented strains had the
same endogenous plasmid content (data not shown). Expression of
BBK32 in the complemented strain was lower than the expression
observed in the infectious strain (8.02/+1.8%), but even this reduced
expressionwassufficient to restoretransientanddragginginteractions
to the level observed with the infectious strain (Fig. 4A and B).
However, stationary adhesion rates in the bbk32 complementation
strain did not reach the same levels as in the infectious strain
(Fig. 4C), implying either a greater dependence upon BBK32 or a
dependence upon additional spirochete factors that were missing in
the complemented non-infectious strain. Attempts to genetically
disrupt the bbk32 locus in the infectious strain were successful, but did
not result in usable constructs due to loss of endogenous plasmids
(lp28-1 and others) in all recovered strains.
PCR amplification and sequencing of all candidate B. burgdorferi
adhesin genes identified to date also indicated that other candidate
adhesin genes (bbf32, bbk2.10, bbO39 and bbm38, encoding VlsE,
OspF, ErpL and ErpK, respectively) were absent or mutated in the
non-infectious parental strain (Table S1). Hence, these genes
were not essential for transient and dragging interactions with the
microvasculature of murine skin in vivo, since expression of BBK32
alone in this strain was sufficient to restore transient and dragging
interactions. However, the possibility still exists that some of these
genes play a role in stationary adhesion.
Examination of the sequence, expression and localization of two
other major adhesins, P66 and Bgp, which have been shown to
associate with integrins and GAGs respectively under static
conditions in vitro, indicated that these proteins were expressed
and localized similarly in non-infectious and infectious strains, and
were not mutated (Fig. 4D; Table S1). Therefore, neither P66
nor Bgp expression nor localization was sufficient for transient or
dragging interactions in the absence of BBK32 expression.
Although the genomic sequence of the P66- and Bgp-encoding
genes was identical in both infectious and non-infectious strains, it
remains possible that secondary mutations elsewhere in the
genome of non-infectious B. burgdorferi could have negatively
affected transient and dragging interactions.
Plasma Fn is essential for B. burgdorferi transient and
dragging microvascular interactions in vivo
Because BBK32 binds Fn in addition to GAGs, we also
investigated a possible role for Fn in the adhesion of B. burgdorferi to
Figure 3. Role of host GAGs in spirochete microvascular
interactions in vivo. The role of host GAGs was examined by
conventional IVM performed using infectious B. burgdorferi preincubat-
ed with dextran sulfate (D–F) or with mice pre-injected with dalteparin,
a therapeutic heparin compound (A–C). The percentages above the
bars for dalteparin- or dextran sulfate-treated spirochetes indicate the
treatment group interaction rate expressed as a percentage of the
interaction rate of untreated spirochetes. For the dextran sulfate
experiments, a total of 7,987 interactions in 96 venules from 14 mice
(n=8 and n=6, respectively, for experiments performed with untreated
and dextran sulfate-treated B. burgdorferi) were analyzed. Microvascular
interactions were measured between 5 and 45 minutes after spirochete
injection. Average time after injection: untreated (17.82/+9.8 min),
treated (18.12/+9.5 min). For the dalteparin experiments, a total of
13,951 interactions in 77 venules from 13 mice (n=7 and n=6,
respectively, for experiments performed with untreated and dalteparin-
treated mice) were analyzed. Microvascular interactions were measured
between 5 and 45 minutes after spirochete injection. Average time
after injection: untreated (15.72/+6.8 min), treated (16.32/+7.1 min).
doi:10.1371/journal.ppat.1000169.g003
Dissemination of B. burgdorferi
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is an important component of the BSK-II medium used to
propagate B. burgdorferi; therefore, we investigated whether
antibodies to rabbit plasma Fn could disrupt B. burgdorferi
microvascular interactions in vivo. Anti-Fn IgGs did not alter
spirochete morphology or motility in vitro, implying that they were
not toxic to B. burgdorferi. The tethering, dragging and stationary
interactions/min for infectious B. burgdorferi treated with aFn IgGs
were compared to the interaction rates of untreated spirochetes,
and of spirochetes treated with nonspecific goat IgGs (Fig. 5).
Preincubation of infectious spirochetes for 20 minutes with the
IgG fraction of goat antiserum to rabbit plasma Fn, together with
intravenous injection of this IgG fraction into the blood stream of
mice, reduced transient and dragging microvascular interactions
by 92% and 99%, respectively (Fig. 5A and B). When the same
treatment regimen was performed using nonspecific goat IgGs, no
effect on interaction rates was observed, indicating that the
reduction in interactions following treatment with aFn IgGs was
specific. Although stationary adhesions were essentially abolished
by the aFn treatment (Fig. 5C), the reduction in transient and
dragging interaction rates was so great that we could not
determine if stationary adhesion rates were specifically affected
by treatment with anti-Fn IgGs. Interestingly, interaction rates
returned to normal levels 15–20 minutes after injection of the
spirochetes and antibody (data not shown), suggesting that
antibody-blocked rabbit Fn bound to spirochetes might have been
replaced by mouse Fn in vivo, thus restoring microvascular
interactions. The long population doubling time of B. burgdorferi
(6–8h) precludes the possibility that restored interaction rates were
caused by spirochete replication. The dramatic reduction in
transient and dragging interactions resulting from Fn antibody
treatment suggested that B. burgdorferi exploits host Fn for these
interactions with the host microvasculature in vivo.
Fibronectin sequences that bind heparin but not RGD-
dependent integrins mediate transient and dragging
microvascular interactions in vivo
Although experiments performed with anti-Fn IgGs suggested
that Fn played a major role in the initiation of microvascular
interactions, it was possible that IgG-dependent inhibition was
partly a result of factors such as steric hindrance of interactions by
bulky IgGs. Therefore, we also investigated the Fn dependence of
interactions using Fn peptides. Fn is a structurally and functionally
complex molecule (reviewed in [33]). Briefly, the N-terminal Type
I Fn repeats and gelatin-binding region interact with Fn-binding
Figure 4. Role of B. burgdorferi GAG- and Fn-binding protein
BBK32 in spirochete-microvascular interactions in vivo. (A–C)
Interaction rates of three B. burgdorferi strains, infectious, non-infectious
and the non-infectious strain with GFP and BBK32 expressed from the
same plasmid (bbk32 knock-in), as analyzed using conventional IVM. A
total of 19,380 interactions in 81 venules from 16 mice (n=9 infectious;
n=3 non-infectious; n=4 non-infectious+bbk32) were analyzed. Micro-
vascular interactions were measured between 5 and 45 minutes after
spirochete injection. Average time after injection: infectious (13.42/
+9.9 min), non-infectious (12.12/+4.8 min), bbk32 knock-in (13.02/
+5.8 min). D) Expression and surface localization of adhesins P66 and
Bgp in non-infectious and infectious strains, as determined by
immunoblotting. The top panel shows total protein loaded for each
strain, detected by Coomassie staining of the SDS-PAGE gel. To identify
cell surface localized proteins, cell pellets were incubated in the
presence (+) or absence (2) of proteinase K (ProK) before lysis.
Proteinase K treatment resulted in a dramatic decrease in the level of
P66 in both the infectious and non-infectious strains used here. Bgp
showed a lesser, but similar reduction in both the infectious and non-
infectious strain following treatment with Proteinase K.
doi:10.1371/journal.ppat.1000169.g004
Dissemination of B. burgdorferi
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[16,34,35]. The central cell-binding domain contains multiple
integrin-binding sites, including the canonical RGD sequence,
which binds to most integrins that have been implicated in B.
burgdorferi-host cell interactions to date [17,19,33]. Finally, the Fn
C-terminus contains a high affinity heparin-binding domain that
also interacts with host cell GAGs [33].
To investigate endothelial cell molecules associating with
spirochete-bound Fn, we used peptides derived from the C-
terminal heparin-binding domain and the integrin-interacting cell-
binding domain in an attempt to block B. burgdorferi-microvascular
interactions in vivo (Fig. 6). The heparin domain peptide (FN-C/H
II: KNNQKSEPLIGRKKT) inhibits Fn-mediated cell adhesion
and heparan sulfate binding [36], and the GRGDS cell-binding
domain peptide is a well-studied competitive antagonist of integrin
binding [37] that also inhibits B. burgdorferi interactions with
integrins aIIbb3, avb3 and a5b1 in vitro [15]. Peptides were injected
via the femoral vein immediately before inoculation with infectious
spirochetes, at concentrations (,50 mg/ml of circulating blood)
that disrupt leukocyte adhesion and recruitment in vivo [38].
Microvascular interactions in dermal postcapillary venules were
recorded for no longer than 20 minutes after injection of peptide
as the effect of peptide treatment on interaction rates was
diminished at later time points, presumably because linear
peptides are rapidly cleared from the mouse circulation [39].
Intravenous injection of 100 mg of the heparin-binding domain
peptide reduced transient interaction rates by 52%, and impaired
both dragging interactions and stationary adhesion levels by 84%,
confirming the role of GAGs in early stages of microvascular
interaction (Fig. 6A–C). In contrast, competition with the RGD
peptide did not significantly inhibit any class of interaction
(Fig. 6D–F), even though the estimated final concentration of this
peptide in the mouse circulation (100 mM) was twice as high as the
dose known to reduce in vitro B. burgdorferi-integrin interactions by
at least 75% in vitro [15]. Administration of twice as much RGD
peptide (,200 mM final concentration) did not inhibit interac-
tions, nor did intravenous administration of anti-CD41 and
CD49e antibodies that respectively target RGD-dependent B.
burgdorferi-interacting integrins containing aIIb or a5 chains (platelet
glycoprotein aIIbb3 and the a5b1 Fn receptor; data not shown).
The effect of treatment with antibodies to avb3 was not examined;
however, since treatment with RGD peptide in vitro has been
shown to strongly inhibit B. burgdorferi binding to this integrin as
well as glycoprotein aIIbb3 and integrin a5b1, it seems unlikely that
integrin avb3 mediated the early stages of microvascular
interactions. The conclusion that RGD-dependent integrins are
not required for microvascular recruitment is consistent with the
localization of known B. burgdorferi-associating RGD-dependent
integrins, which are found at sites of endothelial attachment to
extracellular matrix, and not in the lumen [15]. Collectively, these
results implied that Fn-dependent transient and dragging interac-
tions in vivo were mediated by host GAGs and not by RGD-
dependent integrin interactions.
Discussion
In this study we employed intravital microscopy, a live cell
imaging technique commonly used to analyze leukocyte recruit-
Figure 5. Role of host Fn in spirochete-microvascular interac-
tions in vivo. (A–C) The role of host Fn in microvascular interactions
was examined by conventional IVM performed using infectious B.
burgdorferi preincubated with goat IgGs against rabbit Fn (aFn) or with
non-specific goat IgGs. Non-specific or aFn IgGs were also injected
directly into the mouse blood stream immediately before inoculation
with spirochetes, and the effect of antibody on B. burgdorferi
interactions was measured for up to 20 minutes after spirochete
injection. The percentages above the bars for Fn antibody treatments
indicate the interaction rate expressed as a percentage of the
interaction rate of untreated spirochetes. A total of 2,614 interactions
in 49 venules from 12 mice (n=4 each for experimental group) were
analyzed. Average time after injection: untreated (9.42/+4.4 min), IgG
(10.42/+4.9 min), aFn (10.52/+4.8 min).
doi:10.1371/journal.ppat.1000169.g005
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molecular basis of B. burgdorferi dissemination in vivo. Our results
demonstrate that IVM can provide critical insight into the
mechanisms of pathogen dissemination. Fig. 7 provides a
summary of the features of B. burgdorferi dissemination which we
have identified using IVM, based on data described in this study
and in a recent companion report [9].
This study revealed pivotal roles for the B. burgdorferi adhesin
BBK32 as well as host GAGs and fibronectin in the initiation of
spirochete-microvascular interactions (see below) (Fig. 7). Al-
though other host and B. burgdorferi molecules may also contribute
to microvascular interactions in vivo, the involvement of GAGs and
Fn in this process is especially interesting, since a broad array of
pathogens are known to interact in vitro with these host molecules
in direct binding assays and tissue culture models (reviewed in
[29,42–45]. However, the potential contribution of these interac-
tions to processes such as hematogenous dissemination has not
been directly examined in living hosts.
Evidence for mechanistically distinct stages in B.
burgdorferi microvascular dissemination in vivo
We found that BBK32 and its host ligands Fn and GAGs played
major roles in transient and dragging interactions. Although we
cannot rule out the possibility that these molecules also contribute
to stationary adhesion, the results of the bbk32 complementation
experiments indicate that additional spirochete molecules are
likely required for stationary adhesion. This implies that stationary
adhesion is a mechanistically distinct step in B. burgdorferi
dissemination. This conclusion is supported by our previous
observations that: 1) stationary adhesions form primarily at
endothelial junctions, whereas short-term interactions occur
chiefly on endothelial cells themselves; and 2) stationary adhesions
associate more intimately with the endothelium than short-term
interactions and appear to traverse the surface of the endothelium
when these cells are labeled with PECAM-1 (Fig. 7) [9]. These
observations imply that B. burgdorferi dissemination shares func-
tional similarities with the sequence of events that constitute the
leukocyte recruitment cascade [46,47], as well as the events
associated with dissemination of circulating tumor cells [48].
Leukocyte recruitment is initiated by selectin-mediated tethering
and rolling interactions that permit firm adhesion, which is
mediated by integrins. The initiation phase of leukocyte
recruitment is a rate-limiting step, as it is essential for all
subsequent events in the recruitment cascade. Similarly, we
propose that transient and dragging interactions mediated by
GAGs and Fn together constitute the corresponding initiation
phase of B. burgdorferi dissemination, while other host and
spirochete molecules become essential at the stationary adhesion
phase.
Though our data indicated that transient and dragging
associations were mediated by the same host and spirochete
molecules, the observation that the low molecular weight heparin
dalteparin inhibited only dragging interactions was surprising. The
reason for this is currently unknown, but may result from
Figure 6. Contributions of GAG-binding sequences and
integrin-binding sequences in Fn to spirochete-microvascular
interactions in vivo. The roles of host glycosaminoglycans (GAGs) and
integrins in Fn-mediated spirochete interactions with the microvascu-
lature in vivo were examined by injecting mice with peptides
corresponding, respectively, to a portion of the Fn heparin-binding
domain (A–C) or the Fn RGD sequence (D–F). Microvascular
interactions of infectious B. burgdorferi were examined by conventional
IVM, for up to 20 minutes after intravenous inoculation of spirochetes.
The percentages above the bars for peptide treatments indicate the
interaction rate expressed as a percentage of the interaction rate of
untreated spirochetes. For the heparin-binding Fn peptide experiments,
a total of 8,346 interactions in 64 venules from 11 mice (n=5 and n=6,
respectively, for experiments performed with untreated and peptide-
treated mice) were analyzed. Average time after injection: untreated
(10.82/+3.6 min), treated (10.02/+4.2 min). For the integrin-blocking
Fn RGD peptide experiments, a total of 22,094 interactions in 89
venules from 16 mice (n=9 and n=7, respectively, for experiments
performed with untreated and peptide-treated mice) were analyzed.
Average time after injection: untreated (13.22/+9.7 min), treated
(12.42/+6.0 min).
doi:10.1371/journal.ppat.1000169.g006
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of the carbohydrate moieties.
A role for Fn, GAGs and BBK32 in the initiation of B.
burgdorferi microvascular interactions
This study identified a central role for the B. burgdorferi protein
BBK32, host GAGs and Fn in the initiation of microvascular
interactions. This observation was unexpected, since previous
studies have shown that genetic disruption of bbk32 attenuates but
does not abolish infectivity [49,50]. However, bbk32 disruption
mutants still bind Fn [49,50], implying that other functionally
redundant Fn-binding proteins in B. burgdorferi might also mediate
the initiation of dissemination. The simplest interpretation of our
data is that initiation is mediated by BBK32 interactions with
GAGs, either independently or via a fibronectin bridge. It is
possible that initiation might also be mediated by RGD-
independent integrins such as a3b1, which interacts with Fn,
GAGs and the B. burgdorferi protein BBB07 [18,19]; however, this
integrin is expressed at endothelial junctions [51] implying that it is
more likely to mediate stationary adhesion or extravasation than
initiation interactions. Furthermore, the activation of adhesive
properties by endothelial integrins generally requires endothelial
activation [46], which is not detected in the short time frame of
our experiments [9]. Taken together, these data make it unlikely
that integrins play a role in the initiation of vascular adhesion.
All molecules to date implicated in tethering under shear force
conditions (selectins, von Willebrand factor the E. coli FimH adhesin)
interact with sugar-containing ligands [52,53], suggesting that Fn-
dependent or -independent interactions between BBK32 and GAGs
might promote B. burgdorferi tethering by a similar mechanism. The
affinity of BBK32 for GAGs is unknown, but in the absence of shear
forces BBK32 associates with high specificity and probable high
affinity to the Fn N-terminus via a tandem b-zipper mechanism
shared with Fn-binding proteins of Staphylococcusaureus and Streptococcus
pyogenes [34,35,54,55]. In the absence of shear forces, the affinity of
plasma Fn for heparin (Kd=0.1–1.0 mM) is within the affinity range
of P- and E-selectins for their ligands (Kd=1.5mMa n d1 0 9mm,
respectively) [56,57], suggesting that BBK32-, GAG- and Fn-
dependent initiation interactions may be mechanistically feasible.
Although under shear stress conditions Fn does not bind to the
leukocyte Fn receptor VLA-4, which mediates tethering to
endothelial VCAM-1 under flow [58], previous reports indicate that
both platelets and Mycobacterium tuberculosis can bind to immobilized
Fn in vitro under shear stress conditions that mimic those found in
postcapillary venules [59,60]; interestingly, platelet-Fn interactions
are almost completely blocked by treatment with unfractionated or
high molecular weight heparin [60]. This suggests the possibility that
Fn-dependent tethering interactions entail cooperative GAG binding,
a conclusion that is consistent with our observation that expression of
the Fn- and GAG-binding BBK32 protein was sufficient to restore
initiation interactions to wild-type levels.
Another possibility is that BBK32-induced conformational
changes in Fn might facilitate Fn- and GAG-dependent tethering
interactions. This hypothesis stems from recent data from the Ho ¨o ¨k
laboratory indicating that BBK32 binding to Fn induces the
formation of superfibronectin (S. Prabhakaran and M. Ho ¨o ¨k,
personal communication), a high molecular weight Fn complex that
substantially enhances adhesion of cells to Fn by integrin-dependent
and independent mechanisms [61]. Further analysis of the precise
mechanisms underlying BBK32-, Fn- and GAG-dependent dissem-
ination under shear force conditions will be required.
The results of this study emphasize the importance of directly
investigating host-pathogen interactions in a native context where
major regulators of interaction such as fluid shear stress are
present. The methodology and observations presented here
provide the first direct insight into the role of host GAGs, Fn
and a B. burgdorferi protein that binds both of these host
components, in host microvascular interactions in situ. These
results may have broad-reaching implications for our understand-
ing of processes underlying the dissemination of a variety of other
bacterial pathogens that interact with Fn and GAGs.
Materials and Methods
Construction of the BBK32 expression plasmid pTM170
Plasmid pTM170 was constructed by PCR amplification of the
PospC-driven bbk32 cassette from pBBK32 [25] with flanking KpnI
and FspI sites, using primers B1093 (59-GGTACCTTAATTT-
TAGCATATTTGGCTTTG-39) and B1094 (59-
GGCCTGCGCATTAGTACCAAACGCCATTCTTG-39). The
PCR product was cloned into the GeneJet plasmid, using the Gene
Jet blunt cloning kit (MBI Fermentas) to generate pTM169. The
KpnI/FspI-digested pTM169 insert was cloned into the KpnI/FspI
sites of the GFP-encoding plasmid pTM61 [9] to yield pTM170.
B. burgdorferi transformations and screening
B. burgdorferi strains used in this study were GCB705 (non-
infectious strain B31-A transformed with pTM61) [9,62], GCB726
Figure 7. Schematic summarizing the stages of infectious B. burgdorferi interaction with and escape from the microvasculature.
Based upon our previous work [9] and this study, we propose that transient and dragging interactions together constitute the essential first step
(initiation) of microvascular interactions. We also propose that initiation interactions are mechanistically distinct from downstream interaction events
(described in our recent paper [9]) for two reasons: 1) stationary adhesions and transmigrating spirochetes localize to different sites on the
endothelium than transient and dragging interactions, and 2) stationary adhesion appears to require host and/or spirochete molecules in addition to
or other than BBK32, GAGs and Fn. The results reported in this study do not indicate whether BBK32-mediated initiation events are entirely
dependent on BBK32-GAG interactions bridged by Fn, or whether direct BBK32-GAG interactions also contribute to initiation.
doi:10.1371/journal.ppat.1000169.g007
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pTM61) [9,63] and GCB769 (non-infectious B31-A transformed
with pTM170). The plasmid content of these strains is noted in
Table S1. All strains were grown in BSK-II medium prepared in-
house [64]. Electrocompetent B. burgdorferi strains were prepared as
described [9,65]. Liquid plating transformations were performed
with 50 mg pTM61 or pTM170 in the presence of 100 mg/ml
gentamycin as described [66,67]. Gentamycin-resistant B. burgdor-
feri clones were screened for: 1) the presence of aacC1 sequences by
colony screening PCR performed with primers B348 and B349 as
described [68]; 2) GFP expression by conventional epifluorescence
microscopy, and 3) BBK32 expression, as detected by immuno-
blotting (for bbk32 complementation strains). The presence of
plasmids in non-integrated form in fluorescent strains was
confirmed by agarose gel electrophoresis of total genomic DNA
prepared on a small scale as described [69]. PCR screening for
native plasmid content was performed as described [68,70].
PCR amplification and sequencing of candidate genes
Gene sequences were amplified from genomic DNA prepara-
tions of GCB705 and GCB726. PCR was performed with Phusion
DNA polymerase (NEB, Pickering, Ontario, Canada), according
to manufacturer’s instructions. Sequencing was performed by the
University of Calgary DNA Services. All primers used for PCR
amplification and sequencing are provided in Table S1.
Protein expression and localization studies
The expression and outer membrane localization of adhesins
P66 and Bgp were analyzed as previously described [16,25].
Briefly, for each strain, two pellets containing 5610
7 spirochetes
were washed twice with PBS+2% BSA. PBS containing 5 mM
MgCl2 was added without dislodging pellets. Proteinase K was
added to one pellet to a concentration of 4 mg/ml. After 30 min
incubation at room temperature, reactions were stopped with
150 mg phenylmethylsulfonyl fluoride, spirochetes were pelleted
and washed twice with PBS+0.2% BSA, and pellets were lysed
using SDS-PAGE loading dye. Proteins were resolved by
electrophoresis on 12% SDS-PAGE gels, transferred to nitrocel-
lulose membranes, followed by immunoblotting with antibodies to
P66, Bgp or BBK32, as previously described [17,22].
Preparation of fluorescent B. burgdorferi for direct
bloodstream injection, surgical preparations and
intravital microscopy conditions
These conditions have been described in detail previously [9].
Quantification of spirochete interactions was performed as
recently described [9]. All animal studies were carried out in
accordance with the guidelines of the University of Calgary
Animal Research Centre.
Quantification of leukocyte recruitment in dermal
microvasculature of mice in the presence and absence of
infectious B. burgdorferi
Leukocyte recruitment studies were carried out as previously
described [28]. Briefly, animals were injected with 50 ml of 0.05%
(i.v.) rhodamine 6G (Sigma-Aldrich). Fluorescence was visualized
by epi-illumination using 510 and 560 filters. Leukocytes were
considered adherent to the venular endothelium if they remained
stationary for 30 s or longer. Experiments were performed in mice
that had been intravenously inoculated with 4610
8 infectious B.
burgdorferi grown for 48h in 1% mouse blood, as previously
described, and also with mice that were not inoculated with
spirochetes. Leukocyte adhesions were counted in the dermal
postcapillary venules of infected and non-infected mice from
5 minutes after injection of spirochetes and/or rhodamine until at
least 1 hour from injection, in order to monitor leukocyte
recruitment during the time frame that is used for all experiments
reported in this study.
Fibronectin antibody experiments
GCB726 spirochetes prepared as described above were
resuspended to 2610
9/ml in PBS. The IgG fraction of polyclonal
goat anti-rabbit plasma Fn serum or non-specific goat IgGs
(Cappel/MP Biomedicals, Solon, OH) were added to 1 mg/ml
final. After mixing for 30 min at room temperature, spirochetes
were directly injected into the mouse bloodstream, along with
2 mg of Fn antiserum IgGs or non-specific IgGs.
Fn peptide experiments
GCB726 spirochetes were prepared and injected as described
above, together with 100 mg of GRGDS or FN-C/H II peptide
(Sigma Canada, Oakville, ON; catalogue numbers G4391 and
F7049, respectively), injected via the femoral vein. Peptides
injected at this amount are known to disrupt leukocyte adhesion
and recruitment in vivo [38].
Dalteparin and dextran sulfate experiments
Two hundred ml of a 25 I.U./ml solution of dalteparin (Fragmin:
Pfizer Canada, Kirkland, PQ) were injected via the femoral vein
15 minutes before intravenous inoculation with infectious spiro-
chetes. This concentration has previously been shown to inhibit
leukocyte rolling in vivo [32]. Dextran sulfate-treated spirochetes
were incubated with 20 mg/ml dextran sulfate (500 kDa; Fisher
Scientific Canada, Ottawa, ON) in a final volume of 100 ml PBS
for 30 min at RTuC, followed by 2 100ml washes with PBS.
Spirochetes were resuspended to 2610
9/ml in PBS, and injected
as previously described [9]. The concentration of dextran sulfate
used in these preincubations (20 mg/ml) is the dose that maximally
inhibits B. burgdorferi interaction with endothelial cells in vitro, and
does not affect spirochete morphology or motility [30,31].
Integrin-targeting antibody experiments
One hundred mg anti-CD41 monoclonal Ab (Clone MwReg30;
Becton Dickinson, San Diego, CA), or 20 mg CD49e monoclonal
Ab (clone 5H10-27; Pharmingen, Oxford, UK) were intravenously
administered immediately prior to injection of spirochetes. These
quantities of anti-CD41 and CD49e antibodies are those that
respectively protect against Plasmodium berghei infection in vivo [71],
and which inhibit neutrophil migration in vivo [72].
Statistics
For quantitative analysis, average and standard error values for
different variables were calculated and plotted graphically for all
vessels from all mice using GraphPad Prism 4.03 (GraphPad
Software, Inc., San Diego, CA). Statistical significance was
calculated in GraphPad Prism using a two-tailed non-parametric
Mann Whitney t-test with a 95% confidence interval.
Supporting Information
Table S1 PCR amplification and sequencing of candidate B.
burgdorferi adhesin genes.
Found at: doi:10.1371/journal.ppat.1000169.s001 (0.05 MB
DOC)
Video S1 Spinning disk confocal IVM video footage of
fluorescent B. burgdorferi interacting with a postcapillary venule of
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scale at bottom left. Direction of blood flow is down and to the left.
Found at: doi:10.1371/journal.ppat.1000169.s002 (1.1 MB SWF)
Video S2 Conventional epifluorescence IVM video footage of
fluorescent B. burgdorferi interacting with a postcapillary venule of
the skin vasculature. The video is shown in real time (time
indicated at the bottom). Blood flow direction is to the right and
up.
Found at: doi:10.1371/journal.ppat.1000169.s003 (1.9 MB SWF)
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